Arecor's Unattributed VC - II Round

Arecor raised a round of funding on March 05, 2013. Investors include DSM Venturing.

Arecor has developed a technology that is used in the formulation of biopharmaceuticals. The company's product, Arestat, can stabilize protein-based drugs and vaccines from degradation associated wit…

Articles about Arecor's Unattributed VC - II Round: